- Home
- ARCT vs LANV Comparison
ARCT vs LANV Comparison
Compare ARCT & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | LANV |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 175.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | LANV |
|---|---|---|
| Price | $8.57 | $1.61 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.11 | N/A |
| AVG Volume (30 Days) | ★ 315.4K | 15.5K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | $3.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $1.03 |
| 52 Week High | $24.14 | $2.69 |
Technical Indicators
Market Signals| Indicator | ARCT | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 51.39 |
| Support Level | $6.08 | $1.39 |
| Resistance Level | $8.97 | $1.81 |
| Average True Range (ATR) | 0.44 | 0.13 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 34.76 | 65.00 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.